Product Code: ETC131332 | Publication Date: Jun 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The Malaysia antidiabetics market is estimated to grow at a CAGR of 3.9% during the forecast period. This growth can be attributed to an increase in diabetes prevalence due factors such as rising disposable incomes, changing lifestyle habits & dietary patterns, increasing awareness about diabetes prevention and management methods among people. The high cost of insulin drugs coupled with limited access remains one of the major challenges for the growth prospects of this market
Malaysia Antidiabetics |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Antidiabetics Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Antidiabetics Market Revenues & Volume, 2020 & 2027F |
3.3 Malaysia Antidiabetics Market - Industry Life Cycle |
3.4 Malaysia Antidiabetics Market - Porter's Five Forces |
3.5 Malaysia Antidiabetics Market Revenues & Volume Share, By Product, 2020 & 2027F |
3.6 Malaysia Antidiabetics Market Revenues & Volume Share, By Patient Population, 2020 & 2027F |
3.7 Malaysia Antidiabetics Market Revenues & Volume Share, By Route of Administration, 2020 & 2027F |
4 Malaysia Antidiabetics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Malaysia Antidiabetics Market Trends |
6 Malaysia Antidiabetics Market, By Types |
6.1 Malaysia Antidiabetics Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Antidiabetics Market Revenues & Volume, By Product, 2018 - 2027F |
6.1.3 Malaysia Antidiabetics Market Revenues & Volume, By InsulinΒ , 2018 - 2027F |
6.1.4 Malaysia Antidiabetics Market Revenues & Volume, By Drug Class, 2018 - 2027F |
6.2 Malaysia Antidiabetics Market, By Patient Population |
6.2.1 Overview and Analysis |
6.2.2 Malaysia Antidiabetics Market Revenues & Volume, By Paediatric, 2018 - 2027F |
6.2.3 Malaysia Antidiabetics Market Revenues & Volume, By Adult, 2018 - 2027F |
6.2.4 Malaysia Antidiabetics Market Revenues & Volume, By Geriatric, 2018 - 2027F |
6.3 Malaysia Antidiabetics Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Malaysia Antidiabetics Market Revenues & Volume, By Insulin syringe/ Insulin pen, 2018 - 2027F |
6.3.3 Malaysia Antidiabetics Market Revenues & Volume, By Insulin pump, 2018 - 2027F |
6.3.4 Malaysia Antidiabetics Market Revenues & Volume, By Intravenous infusion, 2018 - 2027F |
6.3.5 Malaysia Antidiabetics Market Revenues & Volume, By Oral, 2018 - 2027F |
6.3.6 Malaysia Antidiabetics Market Revenues & Volume, By Others, 2018 - 2027F |
7 Malaysia Antidiabetics Market Import-Export Trade Statistics |
7.1 Malaysia Antidiabetics Market Export to Major Countries |
7.2 Malaysia Antidiabetics Market Imports from Major Countries |
8 Malaysia Antidiabetics Market Key Performance Indicators |
9 Malaysia Antidiabetics Market - Opportunity Assessment |
9.1 Malaysia Antidiabetics Market Opportunity Assessment, By Product, 2020 & 2027F |
9.2 Malaysia Antidiabetics Market Opportunity Assessment, By Patient Population, 2020 & 2027F |
9.3 Malaysia Antidiabetics Market Opportunity Assessment, By Route of Administration, 2020 & 2027F |
10 Malaysia Antidiabetics Market - Competitive Landscape |
10.1 Malaysia Antidiabetics Market Revenue Share, By Companies, 2020 |
10.2 Malaysia Antidiabetics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |